Episurf Medical Management
Management criteria checks 3/4
Episurf Medical's CEO is Pal Ryfors, appointed in Jun 2017, has a tenure of 6.92 years. total yearly compensation is SEK4.50M, comprised of 84.4% salary and 15.6% bonuses, including company stock and options. directly owns 1.12% of the company’s shares, worth SEK1.09M. The average tenure of the management team and the board of directors is 6.9 years and 8 years respectively.
Key information
Pal Ryfors
Chief executive officer
kr4.5m
Total compensation
| CEO salary percentage | 84.4% |
| CEO tenure | 6.9yrs |
| CEO ownership | 1.1% |
| Management average tenure | 6.9yrs |
| Board average tenure | 8yrs |
Recent management updates
Recent updates
Shareholders May Be More Conservative With Episurf Medical AB (publ)'s (STO:EPIS B) CEO Compensation For Now
Apr 03
Here's Why Episurf Medical (STO:EPIS B) Must Use Its Cash Wisely
Feb 27Is Episurf Medical (STO:EPIS B) In A Good Position To Invest In Growth?
Nov 09Will Episurf Medical (STO:EPIS B) Spend Its Cash Wisely?
May 03We're Not Very Worried About Episurf Medical's (STO:EPIS B) Cash Burn Rate
Sep 23Episurf Medical (STO:EPIS B) Is In A Good Position To Deliver On Growth Plans
Oct 30We Think Some Shareholders May Hesitate To Increase Episurf Medical AB (publ)'s (STO:EPIS B) CEO Compensation
May 03Pål Ryfors Is The CEO & Sales Director of Episurf Medical AB (publ) (STO:EPIS B) And They Just Picked Up 2.3% More Shares
Feb 21CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -kr92m |
| Dec 31 2023 | kr5m | kr4m | -kr95m |
| Sep 30 2023 | n/a | n/a | -kr97m |
| Jun 30 2023 | n/a | n/a | -kr94m |
| Mar 31 2023 | n/a | n/a | -kr84m |
| Dec 31 2022 | kr5m | kr4m | -kr77m |
| Sep 30 2022 | n/a | n/a | -kr72m |
| Jun 30 2022 | n/a | n/a | -kr71m |
| Mar 31 2022 | n/a | n/a | -kr69m |
| Dec 31 2021 | kr4m | kr3m | -kr69m |
| Sep 30 2021 | n/a | n/a | -kr67m |
| Jun 30 2021 | n/a | n/a | -kr66m |
| Mar 31 2021 | n/a | n/a | -kr63m |
| Dec 31 2020 | kr4m | kr3m | -kr64m |
| Sep 30 2020 | n/a | n/a | -kr66m |
| Jun 30 2020 | n/a | n/a | -kr69m |
| Mar 31 2020 | n/a | n/a | -kr73m |
| Dec 31 2019 | kr2m | kr2m | -kr70m |
| Sep 30 2019 | n/a | n/a | -kr66m |
| Jun 30 2019 | n/a | n/a | -kr62m |
| Mar 31 2019 | n/a | n/a | -kr59m |
| Dec 31 2018 | kr2m | kr2m | -kr58m |
| Sep 30 2018 | n/a | n/a | -kr58m |
| Jun 30 2018 | n/a | n/a | -kr59m |
| Mar 31 2018 | n/a | n/a | -kr55m |
| Dec 31 2017 | kr2m | kr1m | -kr61m |
Compensation vs Market: Pal's total compensation ($USD409.14K) is above average for companies of similar size in the Swedish market ($USD240.79K).
Compensation vs Earnings: Pal's compensation has been consistent with company performance over the past year.
CEO
Pal Ryfors (40 yo)
6.9yrs
Tenure
kr4,500,000
Compensation
Mr. Pal Ryfors is Independent Director of Vivesto AB since May 2022. He serves as Chief Executive Officer of Episurf Medical AB (publ) since June 2, 2017 and served as its Acting Sales Director since 2021....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 6.9yrs | kr4.50m | 1.12% SEK 1.1m | |
| Chief Financial Officer | 6.9yrs | no data | 0.042% SEK 40.7k | |
| Chief Operating Officer | 4.9yrs | no data | 0.039% SEK 37.4k | |
| Marketing Director | 7.3yrs | no data | 0.0099% SEK 9.6k | |
| President of Episurf Medical Inc | 2.8yrs | no data | 0.025% SEK 24.7k |
6.9yrs
Average Tenure
40yo
Average Age
Experienced Management: EPIS B's management team is seasoned and experienced (6.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 3yrs | kr200.00k | 0.14% SEK 138.1k | |
| Independent Director | 3yrs | kr200.00k | 0.090% SEK 87.0k | |
| Independent Director | 7.3yrs | kr200.00k | 0.11% SEK 108.7k | |
| Member of Clinical Advisory Board & Director | 15.3yrs | kr800.00k | 0.22% SEK 211.5k | |
| Member of Clinical Advisory Board | 8.5yrs | no data | no data | |
| Member of Clinical Advisory Board | 8.5yrs | no data | no data | |
| Member of Clinical Advisory Board | 8.5yrs | no data | no data | |
| Member of Clinical Advisory Board | 8.5yrs | no data | no data | |
| Independent Director | 8yrs | kr200.00k | 0.11% SEK 108.7k | |
| Member of Clinical Advisory Board | 7.3yrs | no data | no data | |
| Member of Clinical Advisory Board | 5.1yrs | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data |
8.0yrs
Average Tenure
66yo
Average Age
Experienced Board: EPIS B's board of directors are considered experienced (8 years average tenure).